Li Hua Zheng
Founder at AnHeart Therapeutics (Hangzhou) Co., Ltd.
Profile
Li Hua Zheng is the founder of AnHeart Therapeutics (Hangzhou) Co., Ltd.
(founded in 2018) and Anbio, Inc. (founded in 2017), where he holds the titles of Member-Supervisory Board and Director respectively.
He is currently the Owner & Founding Partner at Zheng & Karg LLP since 2018.
Dr. Zheng's former positions include being an Independent Director at Orisun Acquisition Corp.
and being the Owner & Founding Partner at Liu, Zheng, Chen & Hoffman LLP from 2015 to 2017.
Dr. Zheng's education history includes a doctorate degree from Baylor College of Medicine in 2006, undergraduate and graduate degrees from Fudan University, and a graduate degree from Fordham University School of Law in 2012.
Li Hua Zheng active positions
| Companies | Position | Start |
|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Founder | 26/11/2018 |
| Anbio, Inc. | Founder | 30/11/2017 |
| Zheng & Karg LLP | Corporate Officer/Principal | 31/12/2017 |
Former positions of Li Hua Zheng
| Companies | Position | End |
|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 30/11/2017 |
| UCOMMUNE INTERNATIONAL LTD | Director/Board Member | - |
Training of Li Hua Zheng
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
| Fordham University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Stock Market
- Insiders
- Li Hua Zheng
